Univar Solutions scientists developed a lidocaine cream built on starch, sorbitol, coconut oil, and beeswax that matched a commercial benchmark on viscosity, assay, and hydration.
|Articles|April 2, 2021
- Pharmaceutical Technology-04-02-2021
- Volume 45
- Issue 4
Peristaltic Pump for Biopharmaceutical Applications
High Purity New England launched the VerderFlex Vantage 5000 peristaltic pump for medium flow at low to medium pressures in biopharmaceutical applications.
High Purity New England launched the VerderFlex Vantage 5000 peristaltic pump for medium flow at low to medium pressures in biopharmaceutical applications.
With a flow rate from 70 µL/min up to 6600 mL/min, the pump includes advanced record keeping and control options, with accuracy within 1% and the option to store up to 30 different programs. The pump also features touch-screen technology that gives users access to downloadable jobs, pump histories, and the ability to remotely monitor the pump through the Verderflex app. Additonally, the touchscreen feature comes equipped with icon-based programming, real-time stamped events, and the option to onboard storage via a USB.
Articles in this issue
over 5 years ago
Advanced Manufacturing Technologies Shift Outside the Boxover 5 years ago
Reshoring and Expanding API Manufacturing Capabilitiesover 5 years ago
Balancing the Art and Science of Topical Drug Formulationover 5 years ago
Focusing on Accelerated Formulation Strategiesover 5 years ago
Understanding the Impact of Annex 1 on Isolator Operationover 5 years ago
Blocking the Threat of Counterfeit Medicinesover 5 years ago
Limitations and Advances in Dissolution TestingRelated to this article
Nate Edwards of Arya Consulting moderates a discussion with Elisabeth Gardiner of Tevard Biosciences and Donny Xu of the RTW Institute about the regulatory and manufacturing hurdles facing rare disease drug developers.
FDA grants ravulizumab accelerated approval in IgA nephropathy after a 43.4% proteinuria cut, signaling new IV biologic demand for drug manufacturers.
Jane Zhang of ETCH Sourcing explains why geopolitics, transparency, and partnership now weigh as heavily as cost and quality when companies choose suppliers, in this episode of Ask the Expert, moderated by Susan J. Schniepp of Nelson Labs.
FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
Ravi Kiran Kaja, PhD, USP, explains what harmonization of extractables and leachables standards looks like in practice.
Jaenisch, Muraru, and Pandey discuss new skills for QC and regulatory teams, plus patient trust, as new approach methodologies reshape pharma.
Nine duloxetine recalls since 2024 show why generic drug manufacturers need route-level nitrosamine risk assessment, not end-product testing alone.
Trending on Pharmaceutical Technology
1
Formulation and Evaluation of a Sustainable Analgesic Cream Utilizing Renewable Bio-Based Ingredients and Green Chemistry Design Principles
2
AAPS PharmSci 360 2026: System Suitability Standards in E&L Testing
3
Nitrosamine Problems and Industry Solutions: PharmTech Explained
4
FDA Approves Bepirovirsen: Why Oligonucleotide CDMOs Should Take Note
5